Observational Study
Copyright ©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 791-801
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.791
Figure 1
Figure 1 Flow chart of participant selection. NAFLD: Nonalcoholic fatty liver disease.
Figure 2
Figure 2 Relationship between total cholesterol to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease by smooth curve fitting. Adjustment variables: Sex, age, body mass index, aminotransferase, aminotransferase, γ-glutamyl transpeptidase, platelets, hepatitis B surface antigen, creatinine, uric acid, triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A1, apolipoprotein B, hepatitis B virus DNA (+), Hepatitis B e antigen (+), nucleoside analogs. TC/HDL-C: Total cholesterol to high-density lipoprotein cholesterol ratio; NAFLD: Nonalcoholic fatty liver disease.